Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease
AUTOR(ES)
Steiner, Robert A.
FONTE
The National Academy of Sciences
RESUMO
Galanin is a neuropeptide with multiple inhibitory actions on neurotransmission and memory. In Alzheimer's disease (AD), increased galanin-containing fibers hyperinnervate cholinergic neurons within the basal forebrain in association with a decline in cognition. We generated transgenic mice (GAL-tg) that overexpress galanin under the control of the dopamine β-hydroxylase promoter to study the neurochemical and behavioral sequelae of a mouse model of galanin overexpression in AD. Overexpression of galanin was associated with a reduction in the number of identifiable neurons producing acetylcholine in the horizontal limb of the diagonal band. Behavioral phenotyping indicated that GAL-tgs displayed normal general health and sensory and motor abilities; however, GAL-tg mice showed selective performance deficits on the Morris spatial navigational task and the social transmission of food preference olfactory memory test. These results suggest that elevated expression of galanin contributes to the neurochemical and cognitive impairments characteristic of AD.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=31200Documentos Relacionados
- Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
- Glutamate deficits in Alzheimer's disease.
- Glutamate deficits in Alzheimer's disease
- Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
- Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice